DevPro Biopharma and Bespak Complete Early Feasibility Studies for New Groundbreaking Albuterol Inhaler
PharmiWeb,
DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol…
DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol…
Pressurized metered dose inhalers (pMDIs) are the dominant form of treatment for millions of asthma sufferers.
The global pulmonary drug delivery systems market was valued at $28.7 billion in 2019, is expected to account for $30 billion…